Catch up on what happened in optometry during the week of September 30-October 4.

The TECNIS Odyssey IOL is a new full vision range IOL built on the TECNIS platform.

Published data from a pair of Phase 3 clinical trials demonstrated a reversal of pharmacologically-induced mydriasis with a favorable safety profile, according. to the company.

Reproxalap was previously found to be statistically superior to vehicle for the primary endpoint of ocular discomfort (P=0.004) in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber clinical trial.

Because the inner retinal function is thought to affect the emmetropization process, study authors suggested that caffeine may be involved in ocular growth.

Opal, the new digital marketplace, will streamline contact lens ordering and allow patients and practices to order select OTC products, according to a news release.

Iris freckles are the most common melanocytic iris lesions, and UV sunlight is a well-known promoter of melanogenesis. Another study reported a higher rate of iris freckles in patients with UV-associated skin cancer.

Transitions was presented the award in the Vision category at SILMO 2024 in Paris, France.

By alternating the focus area—or the clear zone of the lens—and defocus area—the honeycomb-shaped segment of the lens—the spectacle lenses achieve clear vision and manage myopia progression.

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive management techniques, aiming to enhance patient outcomes in glaucoma care.

CVD could impact physicians' ability to identify choroidal melanoma from choroidal nevus.

Pediatric optometrist Dr. Magdalena Stec highlights effective treatment options and practical advice for parents to help manage and control myopia in their kids.

Mark Dunbar, OD, FAAO, emphasizes the critical role optometrists play in the collaborative care of diabetic eye disease.

Three resident eye care providers—Khanh Huang, OD; Anupam Garg, MD, PhD; and Shail Patel, MD—were honored with the Visionary in Eye Care award at EyeCon 2024, which recognizes their achievements and contributions during their residency programs.

Dr. David Chin Yee describes how to spot early signs of geographic atrophy and explores promising new therapies that may slow progression and improve vision.

At this year’s EyeCon, Dr. Adam Ramsey shared his passion for integrating the latest advancements in optometry into practice.

Ultimately, the goal is to help optometrists better understand which cases require urgent or emergent attention versus those that are more benign and can be managed over time.

At EyeCon 2024, Dr. Adam S. Wenick led a symposium on geographic atrophy, covering diagnosis, FDA-approved treatments, and key clinician considerations through case presentations by Dr. Leonard Messner.